• roche logo

Parce que chaque détail compte.

Informez-vous. Connaissez les risques.



Vous trouverez ci-dessous les principales références bibliographiques qui ont permis d'alimenter ce site :

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of High-risk HPV Positive Cytology Negative Women
Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens CM, Wright TL. Am J Clin Pathol 2011; 136:578-586.

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology. Results From the ATHENA HPV Study
Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL. Am J Clin Pathol 2011; 135:468-475.

The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Ctyology. Results from the ATHENA HPV Study
Stoler, MH, Wright TC Jr, Sharma A, Zhang G, Apple R, Wright TL, Behrens CM. Am J Clin Pathol 2012; 137:295-303.

The ATHENA human papillomavirus study: design, methods, and baseline results
Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. Am J Obstet Gynecol 2011; in press.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM. Lancet Oncol 2011, publié en ligne le 23 août 2011 DOI:10.1016/S1470- 2045(11)70188-7.